EN

Bayer and Kumquat Biosciences partner on potential cancer drug in $1.3 bln deal

Bayer AG announced Tuesday that it has entered into an exclusive collaboration agreement with Kumquat Biosciences Inc. to jointly develop a potential new cancer treatment, Azernews reports, citing foreign media.

Find the plan that suits you best.

1 month subscription

Full digital access to all news for 1 month

1.00
Select

3 months subscription

Full digital access to all news for 3 months

2.00
Select
-33%

6 months subscription

Full digital access to all news for 6 months

3.84
Select
-36%

1 year subscription

Full digital access to all news for 1 year

7.10
Select
-41%
Chosen
76
17
azernews.az

10Sources